Skip to content 
Preimplantation Genetic Testing for Aneuploidy (PGT-A): Enhancing IVF Success
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a cutting-edge technique used during in vitro fertilization (IVF) to enhance the chances of a healthy pregnancy. PGT-A involves screening embryos for chromosomal abnormalities before they are implanted in the uterus. This process helps identify embryos with the correct number of chromosomes, increasing the likelihood of a successful pregnancy and reducing the risk of miscarriage.
The PGT-A process begins with the IVF cycle, where eggs are retrieved from the ovaries and fertilized with sperm in a laboratory. Once the embryos reach a specific developmental stage, a few cells are carefully biopsied from each embryo. These cells are then analyzed to determine the chromosomal makeup of the embryos. In some cases, by selecting embryos with the correct number of chromosomes, PGT-A significantly improves the chances of a successful pregnancy.
PGT-A is particularly beneficial for couples with a history of recurrent miscarriages, advanced maternal age, or previous IVF failures. It can also be advantageous for those with known chromosomal abnormalities that may affect embryo development. By ensuring that only chromosomally normal embryos are transferred, PGT-A helps increase the success rates of IVF and offers greater peace of mind to intended parents.
At Nahal Fertility, we use the latest technology and expert analysis to provide comprehensive PGT-A services, ensuring the best possible care for our patients on their journey to parenthood. Our team of experienced embryologists work closely with each patient to tailor the PGT-A process to their specific needs. We utilize state-of-the-art equipment and work with genetic labs that have the latest advancements in genetic testing to provide accurate and reliable results.
In addition to improving IVF success rates, PGT-A can also help reduce the emotional and financial burdens associated with repeated IVF cycles and unsuccessful pregnancies. By identifying the healthiest embryos from the start, patients can avoid the disappointment and stress of failed implantation or miscarriage, making the overall IVF experience more efficient and effective.
Our commitment to excellence extends beyond the laboratory. We provide comprehensive support throughout the entire IVF and PGT-A process, including personalized counselling and detailed explanations of each step. At Nahal Fertility, we believe in empowering our patients with knowledge and support, helping them make informed decisions about their fertility treatment.
Whether you are just beginning your fertility journey or have experienced challenges along the way, we are here to offer cutting-edge solutions and compassionate care. Our goal is to help you achieve your dream of parenthood with the highest chances of success. Trust us to guide you through every step of the PGT-A process, providing the expertise and support you need for a positive outcome.
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M): Ensuring Healthy Offspring
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a specialized procedure used in addition to in vitro fertilization (IVF) to prevent the transmission of specific genetic diseases. PGT-M involves analyzing embryos for known genetic mutations associated with monogenic disorders, such as cystic fibrosis, Huntington’s disease, or sickle cell anemia. By identifying and selecting embryos free from these genetic conditions, PGT-M helps improve the chances of the birth of a healthy child.
The PGT-M process starts with a thorough consultation to understand the patient’s medical history and specific genetic concerns. Once the IVF cycle begins, eggs are retrieved from the ovaries and fertilized with sperm in the lab to create embryos. When the embryos reach a specific developmental stage, a few cells are biopsied from each embryo for genetic analysis. This biopsy is performed with precision to ensure the embryos remain viable for transfer.
Advanced molecular techniques are used to detect the presence or absence of the specific genetic mutations in question. By identifying embryos that do not carry the mutations, PGT-M significantly reduces the risk of passing on serious genetic disorders to the next generation. This testing is particularly beneficial for couples who are carriers of genetic diseases or have a family history of monogenic disorders, providing them with the reassurance of knowing they are taking proactive steps towards having a healthy baby.
At our clinic, we combine state-of-the-art technology with personalized care to offer comprehensive PGT-M services. Our team of experienced embryologists work together with the genetic lab to ensure the highest accuracy in testing and embryo selection. We use cutting-edge techniques, to provide detailed genetic information, allowing for informed decision-making.
PGT-M is not only about preventing genetic diseases but also about offering hope and possibilities to families who might otherwise face significant genetic risks. The emotional journey of undergoing fertility treatments can be challenging, and our compassionate team is here to support you through every step. We provide personalized counselling to help you understand the testing process, interpret the results, and make the best decisions for your family’s future.
Furthermore, we recognize the importance of individualized care. Each patient’s situation is unique, and our approach is tailored to meet your specific needs and concerns. From the initial consultation to the embryo transfer, we are committed to providing a supportive and informative environment, ensuring you feel confident and cared for throughout your journey. Trust our expertise and dedication to guide you through this critical process, making your dream of a healthy family a reality.
